A Study to Assess the Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP, an Autoimmune Disorder That Affects the Peripheral Nerves)
PHASE2
This is a Phase 2 study to evaluate the safety and efficacy of the subcutan...
A Study of Treprostinil and a New Formulation of LY900014 in Healthy Japanese Participants
PHASE1
The aims of this study are to evaluate:
* The safety and tolerability of a...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.